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1. General introduction 
Contemporaneous research in organic synthesis focuses on 
economy. Indeed, the efficiency of a synthetic sequence is more 
than ever corroborated with its conciseness and sustainability 
issues, as witnessed by the tremendous efforts currently directed 
at the development of multiple bond-forming1 and catalytic 
chemical processes.2 The efficiency of a chemical synthesis can 
be measured by parameters such as selectivity and overall yield, 
of course, but also by its raw material, time, human resources and 
energy requirements, as well as the toxicity and hazard of the 
chemicals and the protocols involved. It is thus now recognized 
that the step count is one of the most important criteria when 
evaluating the efficiency of a synthesis. 
If ingeniosity at the strategy level can allow some shortening 
in a synthetic plan, we believe that the most important 
contributions to step-economical synthesis have resulted, and will 
do so in future, from advances in synthetic methodology. More 
specifically, domino3 and multicomponent4 reactions are now the 
corner stone to the economy in synthesis. Domino or/and 
multicomponent reactions have largely been used for the 
synthesis of large libraries of heterocyclic potentially bioactive 
molecules,5 and to a lesser extent, the total synthesis of complex 
molecules.6 Some families of densely functionalized small 
molecules are particularly suited for use in these reactions. In this 
context, 1,3-dicarbonyl compounds are exceptional synthetic 
platforms owing to the presence of four contiguous reaction sites 
with an alternative electrophilic and nucleophilic character, 
which can be modulated by the nature of the substituants. 
In this review, on the basis of selected examples, we will 
highlight the recent developments of 1,3-dicarbonyl compounds 
in domino and multicomponent reactions7 leading to chiral 
products, with an emphasize placed on work published in the last 
five years.8 
2. Diasteroselective domino reactions 
2.1. 1,3-Dicarbonyl compounds as bis-nucleophiles 
Domino processes involving 1,3-dicarbonyl compounds as 
bis-nucleophiles for the creation of at least two C–C bonds are 
often initiated by a conjugate addition. An early example 
involved the use of a β-ketoester in such a reaction for the 
preparation of compound 6 in a single operation from the simple 
substrates 1 and 2 in the presence of base (Scheme 1).9 In this 
example, the domino sequence of the elementary steps is initiated 
by the 1,6-conjugate addition of 1 to the bis-unsaturated ester 2 to 
generate the enolate 3, which after tautomerization provided the 
more stable enolate 4, which in turn underwent an intramolecular 
1,4 conjugated addition to give the bicyclic enolate 5. The latter 
underwent a final Dieckmann cyclization to finally provide the 
tricyclic product 6 in 41% yield from 1. 
 
 
 
Scheme 1. Domino 1,6-addition–Michael–Dieckmann. 
 
A related more recent example of such reactivity was reported 
by our group allowing a general access to 8-oxo-
bicyclo[3.2.1]octanes from the β-ketoester 7 and unsaturated 
aldehydes 8.10 The domino sequence is initiated by a Michael 
addition, prolonged by an intramolecular aldolization to give the 
8-oxo-bicyclo[3.2.1]octane 9 (Scheme 2). The 
diastereoselectivity of the reaction is highly dependent of the 
nature of the R1-R4 groups, and excellent transfer of chirality is 
observed starting form optically active cyclopentanones 7 (R2 ≠ 
H). For example, the 8-oxo-bicyclo[3.2.1]octane (–)-9a is 
obtained in good yield from (+)-7a (R1 = OtBu, R2 = Me). 
 A B S T R A C T  
 
 
 
Modern organic synthesis focuses on the discovery and the development of stereoselective multiple bond-forming transformations allowing 
the creation of several covalent bonds in a single operation. Hence, the number of steps required to obtain a target molecule is reduced, 
which nicely answers to the efficiency and economy criteria of “green chemistry”. In this context, 1,3-dicarbonyl compounds are 
exceptional synthetic platforms due to the presence of four contiguous reaction sites. This functional group density allows cascades of 
elemental steps from simple substrates leading to the selective formation of elaborated molecular architectures. displaying a large 
functional diversity. 
 
 
 
Scheme 2. Domino Michael–aldol carbocyclization. 
 
A similar domino Michael–aldol strategy was developed for a 
total synthesis of the naturally occurring anti-Alzheimer product 
huperzine A.11 The tricyclic compound 11, synthetic precursor of 
huperzine A, was prepared from the bicyclic β-ketoester 10 and 
metacrolein following a Michael–aldol sequence catalyzed by 
tetramethylguanidine (TMG, Scheme 3). In a second approach of 
the same natural product, the key intermediate 12 was obtained 
more efficiently by a palladium-catalyzed reaction with 
trimethylene methane from the same bicyclic β-ketoester 10. 
Scheme 3. Domino Michael–aldol toward huperzine A. 
 
As illustrated above, the C-C difunctionalization of 1,3-
dicarbonyl compounds involves the formation of enolates. In the 
following, the exploitation of the ambident character of enolates 
for C-O difunctionalization will be presented. 
We have proposed a short synthesis of the 
vinylidenetetrahydrofurans 15 via a C-O alkylation sequence 
(Scheme 4).12 The cycloalkanone 13 reacted with 1,4-
dibromobut-2-yne in the presence of K2CO3 by initial C-
alkylation to give the intermediate 14 which then underwent a 
SN2’ O-cyclization according to the empirical rules established 
by Baldwin.13 The vinylidene compounds 15 can then be 
isomerized to the corresponding 1,3-dienes and used in 
subsequent Diels-Alder cycloadditions.14 This reactivity was 
explored with a variety of bis-electrophiles. With 1,3- and 1,4-
dihalides having cis-like configurations, the C-C cycloalkylation 
products were obtained exclusively providing an access to 
bridged bicyclic compounds, while trans 1,4-dihalides (e.g. (E)-
1,4-dibromo-2-butene) gave only the C-O cycloalkylation 
products (Scheme 4).15 
 
 
 
Scheme 4. Domino C-O and C-C cycloalkylation sequences. 
 
Following these results, a related approach using 1,3-
dicarbonyl dianions was developped (Scheme 5).16 The treatment 
of β-ketoester 16 with at least two equivalents of strong base 
such as LDA generates the corresponding dilithio compound 17. 
For kinetic and thermodynamic reasons, this kind of dianion 
reacts with electrophiles preferentially at the γ position.17 Thus, 
when dianion 17 is treated with a bis-electrophile such as (E)-
1,4-dibromo-2-butene, an initial intermolecular SN2 occurs to 
give the monoanion intermediate, which in turn undergoes a 
highly regio- intramolecular SN2’ to give the vinyl-substituted 
tetrahydrofuran 18. Similarly to the above examples, this reaction 
is limited to the synthesis of five-membered ring due to favorable 
stereoelectronic factors.18 
 
 
 
Scheme 5. Domino C-O cycloalkylation sequence from 1,3-dicarbonyl 
dianion. 
 
The use of the carbohydrate derivatives 20 as bis-electrophile 
in this domino reaction is interesting. Indeed, the regioselectivity 
of the SN2/SN2 domino sequence with the dianion 19 can be 
controlled by the nature of the sulfonyl leaving-group. Thus the 
dianion 19 reacts with the tosyl derivative 20a by initial opening 
of the epoxide followed by the O-cyclization involving the 
substitution of the tosylate group to give 21a, whereas the triflate 
20b reacts first by substitution of the triflate, and then opening of 
the epoxide during the O-cyclization to give the regioisomeric 
product 21b (Scheme 6).19 
  
Scheme 6. Regioselective domino C-O cycloalkylation sequence. 
 
2.2. Other reactivity of 1,3-Dicarbonyl compounds 
The use of 1,3-dicarbonyls as bis-electrophiles in domino 
processes for the preparation of chiral compounds is very limited. 
We can highlight here the recent utilization of malonyl dichloride 
in the key step of a synthetic approach to the polyprenylated 
phloroglucinol natural product clusianone (24, Scheme 7). Thus, 
the highly functionalized bicyclo[3.3.1]nonane framework of the 
natural product can be obtained in a single synthetic operation 
from the reaction of the silyl enol ether 22 with malonyl 
dichloride, a precursor of chloroacylketene, to give 23, which 
was then converted to clusianone (24) in few steps.20 
 
 
Scheme 7. Highlight of the total synthesis of clusianone (24). 
 
In a few cases, 1,3-dicarbonyls have been used as both 
electrophilic and nucleophilic reaction partners to prepare chiral 
molecules. As mentioned above, dianions of type 25 react with 
electrophiles preferentially at the γ position. If an aldehyde is 
used as electrophile, an aldolization at the γ position occurs to 
give the intermediate alcoolate 26, which can then undergo an 
intramolecular lactonization to give the β-oxo-δ-lactone 27 
(Scheme 8).21 
 
 
Scheme 8. Synthesis of β-oxo-δ-lactone from 1,3-dicarbonyl compounds. 
 
Another example of related reactivity involves the unsaturated 
ketoester 28. In this case, the electrophilic β position is 
homologated to the δ position via the incorporation of a 
conjugated double bond. This approach was largely developed 
for the synthesis of steroids, and was recently applied to the total 
synthesis of the naturally occurring glycosilated steroid ouabaine 
(32, Scheme 9).22 In the presence of base, the β-ketoester 28 first 
reacts by a diastereoselective Michael addition to the unsaturated 
β-ketoaldehyde 29 to give the intermediate stabilized enolate 30, 
which in turn undergo cyclization following an intramolecular 
Michael addition to give compound 31, a synthetic precursor of 
ouabaine (32). Enantioselective organocatalytic versions of 
related domino Michael–Michael reaction have been developed 
recently (see section 4.1). 
 
Scheme 9. Highlight of the total synthesis of ouabaine (32). 
 
2-Diazo-1,3-dicarbonyl compounds are know to undergo 
thermal or photochemical Wolff rearrangement to give the 
corresponding reactive acylketenes.23 Recently, it was 
demonstrated that such a rearrangement could occur under 
dielectric heating (microwave irradiation), and that the transient 
acylketene can be trapped in a domino process with a variety of 
nucleophiles including alcohols, amines or thiols in nearly 
quantitative yields to provide a general access to α-carbonylated 
cycloalkanones (Scheme 10).24 This approach allowed the easy 
introduction of chiral auxiliaries (35 and 37 for example), the 
preparation of otherwise difficultly available compounds (33, 35 
and 36 for example), and overall, proved superior to existing 
approaches in scope and eco-compatibility. 
 
 
 
Scheme 10. Domino Wolff rearrangement–nucleophilic addition. 
 
3. Diasteroselective multicomponent reactions 
In this section, examples are organized with respect to the 
proposed nature of the first reaction of the sequence. 
3.1. MCRs based on the Hantzsch reaction 
1,4-dihydropyridines (1,4-DHPs) are an important classe of 
bioactive molecules and are also interesting biomimetic reducing 
agents. The synthesis of 1,4-DHPs is generally achieved using 
the four-component Hantzsch reaction, first reported in 1882,25 
which involves the one-pot condensation of an aldehyde, two 
equivalents of a β-ketoester and ammonia or a synthetic 
equivalent (Scheme 11). The reaction proceeds through the 
condensation of in situ formed alkylidene malonate 39 and 
enaminoester derivative 40, followed by a cyclodehydration 
affording the symmetric heterocycle 41. Cyclic 1,3-diketones can 
also participate in this multicomponent sequence, leading to 
hydrogenated acridine derivatives.26 
 
 
Scheme 11. General scheme of the Hantzsch’s 1,4-DHPs synthesis. 
 
Alternatively, when only one equivalent of 1,3-dicarbonyl is 
used in combination with one equivalent of β-ketoester, chiral 
1,4-DHPs may be obtained. Several diastereoselective 
approaches have been studied for the preparation of optically 
active 1,4-DHPs. For example, the use of one of the partners 
under enantiomerically pure form may be a solution. Thus, Rose 
and Draeger described in 1992 a four-component condensation 
between 1,3-cyclohexanedione, 3,4-
(methylenedioxy)benzaldehyde, ammonia and a mandelic 
ketoester derivative 42, leading to the expected dihydropyridine 
43 in up to 98% diastereomeric excess (Scheme 12).27 
 
 
Scheme 12. Diastereoselective synthesis of chiral 1,4-DHPs. 
 
Optically pure 1,4-DHPs may also be accessed through 
chemical resolution, as illustrated by the synthesis of the 
potassium channel opener ZD0947 (Scheme 13).28 An 
unsymmetrical Hantzsch reaction afforded an unusually stable 
tetrahydropyridine 44, which led to the desired bioactive product 
after dehydration, cleavage of the ester, and resolution of the 
corresponding acid with (S)-(α)-methylbenzylamine. An 
organocatalytic enantioselective version of this four-component 
synthesis of bicyclo-1,4-DHPs was recently reported in the 
literature (see section 4.2). 
 
 
Scheme 13. Synthesis of (S)-ZD0947, a potassium channel opener. 
Another possibility for the efficient synthesis of 
unsymmetrical DHPs relies on the condensation between 
aldehydes and 1,3-dicarbonyls in the presence of a preformed 
enamino ester intermediate. Thus, starting from an aldehyde  and 
a enaminoester, the asymmetric synthesis of 1,4-DHP C-
glycoconjugate  was achieved.29 Recently, the same group 
developed the first organocatalyzed C-glycosyl aldehyde 45/β-
ketoester/enamine 46 three-component variant of the Hantzsch 
reaction, leading to the formation of symmetrically and 
unsymmetrically substituted DHP C-glycoconjugates 47 of 
biological relevance, with diastereomeric excesses up to 95% 
(Scheme 14).30  
 
Scheme 14. Organocatalytic diastereoselective synthesis of DHP C-
glucoconjugates. 
This modified Hantzsch approach has recently been exploited 
for the stereoselective synthesis of pyrazolo[4,3-c]quinolizin-9-
ones 48 (Scheme 15).31 Microwave irradiation of a mixture of 
dimedone, aminopyrazole and aromatic aldehyde in the presence 
of tBuOK led to these heterocyclic compounds in moderate to 
good yields. The intermediate unsymmetric Hantzsch product 49 
undergoes a ring opening step followed by an intramolecular 
transamidation to give finally 48. 
 
 
Scheme 15. Microwave-assisted synthesis of pyrazolo[4,3-c]quinolizin-9-
ones. 
 
Finally, when the enamine partner is replaced by a guanidine 
system, the modified MCR evolves through a Knoevenagel–aza-
Michael sequence, leading to polyheterocycles 50 of biological 
interest (Scheme 16).32 Thus, the condensation of 2-amino-1,3,4-
triazole, an aldehyde and a 1,3-dicarbonyl substrate in water at 
room temperature afforded the corresponding bicyclic hemi-
aminals 50 in moderate to good yields. It is noteworthy that in 
most of the cases, only one of the four possible diastereomers is 
formed in this environmentally benign catalyst-free sequence.  
 
Scheme 16. Multicomponent synthesis of 5,6,7,8-tetrahydro 
[1,2,4]triazolo[2,1-b]quinazolinones. 
3.2. MCRs based on the Biginelli reaction 
The Biginelli reaction, discovered by Pietro Biginelli in 
1893,33 is a multicomponent reaction allowing the synthesis of 
3,4-dihydropyrimidin-2-(1H)-ones or -thiones (DHPMs) 51 by 
reacting an urea or thiourea, a 1,3-dicarbonyl derivative and an 
aldehyde (Scheme 17). The increasing interest in DHPMs is 
mainly due to their therapeutic and pharmacological properties.34  
 
 
Scheme 17. General scheme of the Biginelli reaction. 
 
Biginelli products contain a stereogenic center, and the 
influence of the absolute configuration on the biological activity 
has been investigated. Indeed, as two enantiomers may perform 
different or even opposite activities,35 the development of 
representative methods to approach enantioenriched DHPMs is a 
task of primary importance.36 Initially, chemical resolution by 
conversion of racemic compounds into diasteromers was the 
method of choice, affording for example optically pure bioactive 
DHPMs such as SQ-3292637 and the two enantiomers of 
monastrol38 (Figure 1). Alternatively, resolution of racemic 
DHPMs was also attempted via enzymatic hydrolysis of ester 
moieties,39 as illustrated by the preparation of a precursor of (S)-
L-771688.40  
 
 
Figure 1. Optically pure DHPMs obtained via chemical or enzymatic kinetic 
resolution. 
 
Optically active DHPMs were also prepared through 
auxiliary-assisted asymmetric Biginelli synthesis, using chiral 
starting materials such as C-glycosyl substrates.29a As an 
illustration, the synthesis of two diastereoisomers of monastrol 
analogues 52 bearing the ribofuranosyl moiety has been 
successfully achieved (Scheme 18).41 On the contrary, all efforts 
for the synthesis of optically active related DHPMs through 
Biginelli reaction involving (–)-menthol-derived acetoacetate, 
were unproductive since a 1:1 mixture of unseparable 
diastereomers were obtained.42 
 
 
Scheme 18. Synthesis of glycosyl analogues of monastrol. 
 
3.3. MCRs based on the Mannich reaction 
The Mannich reaction consists on the condensation of a C–H-
activated compound with a primary or a secondary amine and a 
non-enolizable aldehyde or ketone to afford β-aminocarbonyl 
derivatives known as Mannich bases. This sequence is of great 
use for the construction of cyclic and acyclic nitrogen-containing 
molecules, and numerous variants have been published. Among 
them, the CoCl2-catalyzed coupling between a 1,3-dicarbonyl 
compound 53, an aromatic aldehyde 54, and acetonitrile in the 
presence of acetyl chloride,43 provides a general access to β-
acetamido carbonyl compounds 55 (Scheme 19). These products 
are the building blocks of numerous pharmaceutical and 
biological compounds, and they can be used as precursors of 1,3-
amino alcohols,44 β-amino acids43 and γ-lactams.45 
 
Scheme 19. Multicomponent synthesis of β-acetamido carbonyl derivatives. 
 
A large number of catalysts have been reported for this 
reaction, with diastereomeric ratio ranging from 50/50 to 98/2.46 
Recently, selectfluor has been described as an efficient green 
catalyst for this transformation, offering advantages such as 
shorter reaction times and high anti-selectivity, especially from 
α-substituted ketones.47 Finally, a variant was reported recently 
involving acetamide in the presence of trimethylchlorosilane.48 
The latter compound acts as a Lewis acid for activation of the 
aldehyde partner. 
The Mannich reaction is also of great use for the construction 
of heterocyclic targets, as illustrated by the recent reports on the 
synthesis of 1,4-diazepane derivatives 59 (Scheme 20). Kita’s 
group49 and our group50,51 reported independently a 
cyclodehydrative three component synthesis of these heterocyclic 
seven-membered rings of biological interest from 1,3-dicarbonyl 
compounds 56, aromatic aldehydes and 1,2-diamines 57. The 
reaction involves the formation of an intermediate 58 bearing 
imine and enamino ester functionalities, which then evolves to 
the final product via an intramolecular Mannich-type 
condensation. The latter step of the sequence corresponds to a γ-
functionalization of the starting 1,3-dicarbonyl. The reaction may 
be conducted either in refluxing 1,2-dichlorethane in the presence 
of para-toluene sulfonic acid (method A) or 4Å molecular sieves 
(method B) as catalyst, or under solvent- and catalyst-free 
conditions (method C). The latter conditions were particularly 
efficient when β-ketoamides were used as substrates. It is 
noteworthy that 1,2-phenylenediamine was not effective in this 
multicomponent reaction, but the access to the corresponding 
1,5-benzodiazepine derivatives were made possible by the 
development of a sequential one-pot protocol involving the 
preliminary acid-catalyzed formation of an enamino ester from 
the 1,2-diamine and a 1,3-dicarbonyl.52 
 
 
Scheme 20. Three-component synthesis of 1,4-diazepane derivatives. 
 
3.4. MCRs based on the Knoevenagel reaction 
The Knoevenagel reaction is the condensation of aldehydes or 
ketones with active methylene compounds, usually in the 
presence of a weakly basic amine.53 The resulting highly reactive 
product 60 can undergo inverse demand hetero-Diels–Alder 
reaction with a dienophile 61 to afford functionalized 
dihydropyrans 62 (Scheme 21). The reaction can be performed as 
a “two-component reaction”, by putting a 1,3-dicarbonyl 
derivative and an aldehyde containing a dienophile moiety 
together, or as a “three-component reaction”, through the use of a 
mixture of a 1,3-dicarbonyl, an aldehyde and a dienophile. This 
multicomponent sequence, known as the “Domino–Knoevenagel 
Hetero-Diels–Alder reaction”, was discovered and intensively 
studied by the group of Tietze.54 As an illustration of its 
potentialities, this domino sequence was reported as a successful 
key step in the first enantioselective syntheses of Ipecacuanha 
alkaloid emetine and Alagium alkaloid tubolisine.55 
 
 
Scheme 21. The « Domino–Knoevenagel–Hetero-Diels–Alder » sequence. 
In this context, some recent examples concern the reactivity of 
1,4-benzoquinones and pyrazolones as 1,3-dicarbonyl 
equivalents under microwave irradiation. Thus, the sequence has 
been successfully extended to the regioselective multicomponent 
construction of bis-pyrano-1,4-benzoquinone derivatives 65a and 
65b from 2,5-dihydroxy-1,4-benzoquinone (63), 
paraformaldehyde and an alkene (Scheme 22).56 Depending on 
the alkene moiety, the reaction yielded only the linear tri-, penta- 
or heptacyclic product in a 1:1 diastereomeric ratio, as illustrated 
with indene (64). 
 
 
Scheme 22. Example of heptacyclic bis-pyrano-1,4-benzoquinone 
derivatives. 
An organocatalyzed microwave-assisted Knoevenagel–
Hetero-Diels–Alder reaction was reported for the synthesis of 
2,3-dihydropyran[2,3-c]pyrazoles 67 from pyrazol-2-one 66 as 
masked synthetic equivalent of 1,3-dicarbonyl (Scheme 23).57 
Using proline derivatives as catalyst in tBuOH, the two 
diastereomers of the desired product were isolated in good yields 
with a 4:1 diastereomeric ratio. 
 
 
Scheme 23. Asymmetric synthesis of 2,3-dihydropyran[2,3-c]pyrazoles from 
pyrazol-2-one. 
 
The Knoevenagel reaction may also be combined with a 
Michael addition in multicomponent sequences. During a study 
on the synthesis of non-natural trytophan and tryptamine 
derivatives, the condensation of indole with Meldrum’s acid and 
aldehyde 68 in acetonitrile, in the presence of a catalytic amount 
of D,L-proline, afforded the corresponding adduct 69 in good 
yield as only one diastereomer (Scheme 24).58 This variant of the 
Yonemitsu reaction was successfully applied to the asymmetric 
synthesis of tryptamine59 and tetrahydro-β-carboline60 
derivatives.  
 
Scheme 24. Domino Knoevenagel–Michael reaction. 
 
A Knoevenagel-based reaction was recently reported for the 
construction of bis-heterocycle (Scheme 25).61 The reaction is a 
four-component Knoevenagel–Michael–oxa-cyclisation 
involving malonitrile, an aldehyde or a ketone, a β-ketoester and 
hydrazine. This methodology was intensively developed with a 
wide range substrates to form a series of these fused heterocyclic 
skeletons, and interestingly enough, when a bulky aromatic 
aldehyde (e.g R2 = 2-methoxynaphtyl ; R3 = H) was used two 
atropoisomers were isolated in a 2:1 ratio. 
 
 
Scheme 25. Four-component synthesis of highly substituted dihydro-
pyranopyrazole derivatives. 
 
 
Knoevenagel reaction has also been combined with 1,3-
dipolar cycloaddition to allow the formation of challenging 
bispiropyrrolidine derivatives 72 (Scheme 26).62 A mixture of 
1,3-indanedione, an aldehyde, sarcosine and a cyclic 1,2-dione in 
refluxing ethanol without any catalyst gave bispiropyrrolidine 
derivatives 72 as a single diastereomer.  This highly regio- and 
stereoselective four-component Knoevenagel–Huisgen 
cycloaddition sequence is of great interest for the synthesis of 
such spiropyrrolidines which are potential antileukemic and 
anticonvulsant agents also exhibiting antiviral properties. A 
reasonable mechanism involves a twofold role of sarcosine, 
which actes both as catalyst for the Knoevenagel condensation 
and as key reaction partner for in situ formation of the 
dipolarophile 73. 
 
 
Scheme 26. Four-component synthesis of functionalized bispiropyrrolidines. 
 
Finally, a domino multicomponent reaction combining a 
Lewis acid catalyzed Knoevenagel condensation, a Nazarov 
cyclisation and an electrophilic fluorination was recently reported 
for the highly diastereoselective synthesis of fluorinated 1-
indanone derivatives 74 (Scheme 27).63 Thus, condensation of an 
aromatic β-ketoester 75 with an aldehyde in the presence of N-
fluorobenzenesulfonimide (NFSI) and AlCl3 in nitroethane at 
room temperature, afforded the desired heterocycles with high 
trans stereoselectivity. 
 
 
Scheme 27. Three-component synthesis of fluorinated trans-1-indanones 
 
3.5. MCRs based on the Michael addition 
In its original form, the Michael addition consisted on the 
addition of diethyl malonate across the double bond of ethyl 
cinnamate in the presence of sodium ethoxide, to afford a 
substituted pentanedioic acid ester.64 Currently, all reactions that 
involve a 1,4-addition of stabilized carbon nucleophiles to 
activated π-systems are known as Michael additions. Among the 
various reactants, enolates derived from β-dicarbonyl compounds 
are substrates of choice due to their easy deprotonation under 
mild conditions. Although this addition with such substrates is an 
old, but still very powerfull and simple reaction, it came to be of 
interest for MCRs only recently, and has emerged as promising 
approach with a wide synthetic potential in heterocyclic 
synthesis. In this context, we will focus in this paragraph on 
recent selected examples of the application of Michael addition-
based MCRs65 to the synthesis of chiral polysubstituted 
heterocycles66 in the five- to seven-membered series. 
The first Michael addition-based MCR with 1,3-dicarbonyls 
was reported by Eschenmoser and co-workers in 1979.67 They 
described a fragmentational approach to macrolides, starting 
from substrates which are accessible through a three-component 
condensation of acrolein, 2-methyl-1,3-cyclohexanedione and 
dimethylmalonate. However, since the publication of these 
preliminary results, such MCRs remained unexplored for over 20 
years. In 2001, we developed the first multicomponent domino 
reaction between 1,3-dicarbonyls, α,β-unsaturated aldehydes or 
ketones and ω-nucleophilic functionalized primary amines 76 in 
the presence of molecular sieves, providing a route to 
polyheterocyclic compounds of synthetic, biological and 
pharmaceutical interests (Scheme 28).68 From a mechanistic point 
of view, the key step of this sequence is the formation of an 
iminium intermediate 77 or 78, which is trapped in situ by the 
nucleophilic function of the amine partner. The structure of the 
corresponding products is highly dependent of the nature of the 
amine. Indeed, diamines, aminoalcohols and aminothiols led 
selectively to the formation of fused polyheterocyclic N/N-, N/O- 
and N/S-aminals with partial to total anti selectivity, while o-
hydroxyaniline afforded a spiro-type tetracyclic compound 79 as 
a single diastereomer (Figure 2). 
 
Scheme 28. General scheme for the multicomponent synthesis of fused- or 
spiro-type polyheterocycles. 
 
 
 
Figure 2. Polycyclic N/N-, N/O- and N/S-aminal synthesis via Michael-
initiated MCRs. 
 
More recently, an extrapolation of this work was proposed for 
the three-component condensation of acrolein, (S)-2-
phenylglycinol and various acyclic 1,3-dicarbonyls in toluene in 
the presence of 4Å molecular sieves for the preparation of 
bicyclic functionalized tetrahydropyridines 80 (Scheme 29).69 
These heterocycles may be used as chiral building blocks for the 
synthesis of alkaloids, as illustrated by the total synthesis of (–)-
lupinine in five steps and 29% overall yield. 
 
 
Scheme 29.  Three-component synthesis of bicyclic tetrahydropyridines. 
 
The introduction of a functionalized pyrrole 81 as the amine 
partner in this sequence allowed us to propose a highly efficient 
access to original pyrrolopiperazine and azasteroid-like scaffolds. 
The key-step consists on the formation of an ene-iminium 
intermediate 82, in situ trapped through a Pictet-Spengler-type 
cyclization. As an illustration of the stereoselective potential of 
this transformation, we were able to prepare a tetracyclic 
compound 83 with an azasteroid skeleton, in high yield and as a 
single 1,4-trans diastereomer (Scheme 30).70  
 
Scheme 30. Totally diastereoselective three-component synthesis of original 
pyrrolopiperazine scaffolds. 
Alternatively, the introduction of various unfunctionalized 
primary amines into this three-component domino reaction 
resulted in the formation of other families of polyheterocycles. 
Thus, the reaction between an ethoxycarbonyl piperidone 84, 
acrolein and a primary amine in refluxing toluene in the presence 
of molecular sieves gave either 1,6-hydronaphthyridines 85 or 
amino azabicyclo[3.3.1]nonanones 86, depending on the 
substitution of the amines (Scheme 31).71 
 
Scheme 31. Selective formation of 1,6-naphthyridines vs azabi-
cyclo[3.3.1]nonanones 
Starting from quite similar reagents, i.e. alkylamines, β-
ketoesters and chalcones, but replacing molecular sieves by CAN 
as catalyst in ethanol, a totally diastereoselective synthesis of cis-
4,6-disubstituted 2-alkylaminocyclohexene-1-carboxylic esters 
87, precursors of densely functionalized β-aminoesters 
containing four stereocenters, was reported (Scheme 32).72 
 
Scheme 32. CAN-catalyzed preparation of 2-alkylamino-1-cyclohexene-1-
carboxylic esters. 
 
Finally, the highest level of complexity for this three-
component reaction was reached when β-ketoamides 88 were 
used as substrates. We demonstrated that these particular 1,3-
dicarbonyls could be involved not only as substrates but also as 
nucleophilic partners through the highly diastereoselective 
synthesis of scaffolds 89 containing an original 2,6-
diazabicyclo[2.2.2]octane skeleton (2,6-DABCO).73 In this 
transformation, two different iminium intermediates 90 and 91 
were successively generated and trapped by two different 
nucleophiles, one being the substrate itself and the other one 
resulting from the heterofunctionalization of the amine partner 
(Scheme 33). 
 
 
Scheme 33. Three-component synthesis of 2,6-DABCO scaffolds. 
The Michael-aldol domino sequence between β-ketoesters of 
type 92 and α,β-unsaturated aldehydes leading to 8-oxo-
bicyclo[3.2.1]octanes of type 93 was presented above (see 
Scheme 2). When the same reaction is conducted in methanol, 
the latter can react as a nucleophile with the 8-oxo-
bicyclo[3.2.1]octane 93, and promotes the retro-Dieckamnn type 
fragmentation of the bicyclic compound into the seven-
membered rings 94 or 95 (Scheme 34).74 This fragmentation is 
favored by the relaxation of the ring tension of the 8-oxo-
bicyclo[3.2.1]octane intermediate, while the analogous less 
strained bicyclo[3.3.1]nonane do not undergo the fragmentation 
under these conditions. The reversible character of the two first 
elemental steps of this domino reaction (Michael addition and 
aldolization) combined with a highly selective retro-Dieckmann 
fragmentation allow a highly diastereoselective access to a 
variety of polysubstituted and functionalized seven-membered 
rings starting from simple and cheap substrates under user and 
environmentally friendly conditions. This reaction, which was 
denominated MARDi cascade following the acronym of the 
domino sequence Michael/Aldol/Retro-Dieckmann, is a 
multicomponent reaction and the final product is the 
condensation product of the β-ketoester 92, the α,β-unsaturated 
aldehyde and methanol. In the case of metacrylic aldehydes (R1 = 
H, R2 ≠ H), the MARDi cascade is prolonged by an 
intramolecular lactonization and an elimination to give the 
cycloheptene carboxylic acid 95. The MARDi cascade is very 
general and can also be realized starting from β-ketosulfones 
with complementary diastereoselectivity and reactivity75 or in the 
heterocyclic series (Figure 3).76 The reaction allows the control of 
up to five newly created stereocenters, and a complete chiral 
induction in the case an optically active β-ketoester precursor. An 
application of the MARDi cascade to the synthesis of the 
tricyclic ring system of guaianolide natural products was reported 
recently.77 
 
 
Scheme 34. The MARDi cascade. 
 
 
 
Figure 3. Selected examples of products obtained by the MARDi cascade. 
 
3.6. MCRs based on other reaction 
As mentioned above, 2-diazo-1,3-dicarbonyl compounds can 
undergo an efficient Wolff rearrangement under microwave 
irradiation to give the corresponding acylketene (see scheme 10). 
In addition to their reactions with nucleophiles,24 acylketenes can 
react as 1,3-oxadienes in inverse demand hetero-Diels–Alder 
reactions, and this reactivity was exploited in a domino three-
component synthesis of oxazinones. Thus, we were able to obtain 
a series of oxazinones 96 from the microwave irradiation of a 
1:1:1 mixture of 2-diazo-1,3-diketone, an aldehyde and a primary 
amine (Scheme 35).78 Under these conditions, the aldehyde and 
the amine partners react together to give the corresponding imine, 
while the diazo compound undergoes the Wolff rearrangement to 
give the corresponding acylketene, which then react with the in 
situ generated imine. The reaction proceeded well with a variety 
of aromatic and aliphatic aldehydes, and with alkyl, allyl, 
propargyl and benzyl amines. With enantiopure primary 
branched amines a modest chiral induction was observed (e.g. 
96d). In the case where both the aldehyde and amine partners are 
specifically choosen to participate in a subsequent intramolecular 
Diels-Alder reaction, the pentacyclic oxazinone derivative 96e 
was obtained allowing the stereocontrolled creation of six 
chemical bonds and four rings in a single catalyst-free reaction in 
fair to good yields in regards of the increase of the molecular 
complexity (Scheme 35). A conceptually related strategy was 
applied to the synthesis of oxazindiones involving concomitant 
Wolff and Curtius rearrangments.78 
 
Scheme 35. Microwave-assisted three-component synthesis of oxazinones. 
 
4. Enantioselective Domino and Multicomponent Reactions 
In the recent years, the growing interest of pharmaceutical and 
agrochemical companies for the production of enantiopure 
molecules has led to unprecedented demand for new 
enantioselective methods. There are many ways to achieve this 
objective using metal-based catalysts or biocatalysts (enzymes) 
but these methods, although they may prove useful on a 
laboratory scale, are limited or even inapplicable to industrial 
level for various reasons (cost, toxicity, laborious processes, 
etc.). 
On the opposite, organocatalysis,79 which has been 
conceptualized in 2000 by the groups of McMillan80 and List81 
answers perfectly to the principles of “green chemistry”82 and has 
already found many applications in synthetic organic chemistry.83 
One of the first example in enantioselective organocatalysis has 
been reported independently by two teams (Hajos/Parrish84 and 
Weichert/Sauer/Eder85) which developed an enantioselective 
intramolecular aldol condensation catalysed by proline 
The purpose of this chapter is to present recent advances in the 
use of 1,3-dicarbonyl derivatives in domino processes and MCRs 
involving enantioselective organocatalysis. The reactions will be 
presented by their type of activation mechanism and the nature of 
the cascade reaction.86 
4.1. Enantioselective Domino Reactions 
Organocatalysis involves several activation modes.83e One of 
the most exploited is probably the enamine-iminium activation 
which use “proline like” catalysts to form with the substrate 
(usually an aldehyde or a ketone) an equilibrium between a 
nucleophilic enamine and an electrophilic iminium that open a 
wide area of reactivity. This is well understood and has been 
already well exploited in diverse domino and cascade reactions. 
This type of cascade reaction has been discussed previously. 
Here, the use of an enantiomerically pure organocatalyst allows 
the control of the chirality in the final product. The discovery of 
(see introduction), although extraordinary for its time, was not 
fully exploited until the early 2000s by Barbas, Inspired by the 
work of Hajos and Parrish, Lerner and List extended this strategy 
and developed a proline-catalyzed asymmetric Robinson 
annulation reaction (Scheme 36).81 This cascade involves two 
different processes, namely a Michael addition followed by an 
aldol condensation. 
 
 
Scheme 36. Enantioselective Robinson annulation. 
The cascade Michael–aldol condensation was then developed 
using α,β-unsaturated aldehydes and malonate 97 for the 
synthesis of highly functionalized chiral cyclopentenes 99 using 
the diphenylprolinol silyl ether 98 as the organocatalyst (Scheme 
37).87 
 
 
Scheme 37. Enantioselective domino Michael–aldol. 
A similar strategy has been employed for the synthesis of 
cyclohexanones 101 with control of four stereogenic centers 
using imidazolidine 100 as the organocatalyst (Scheme 38).88 The 
authors suggest that the reaction is initiated by the formation of 
the Michael adduct with the creation of two stereogenic centers 
where only one is controlled (the one bearing Ar1). Indeed, the 
carbon atom bearing the ester group racemize quickly under the 
reaction conditions. Thus, the Michael adduct exists as an 
equilibrium between syn and anti diastereomers. Fortunately, the 
second step involving an intramolecular aldol reaction is highly 
diastereoselective: the cyclization occurs only with the syn 
Michael adduct. In consequence, only one six-membered ring is 
formed where the ester group, Ar1, Ar2 and R2 are in equatorial 
positions. 
 
 
Scheme 38. Enantioselective domino Michael–aldol. 
 
Recently, a new sequence involving iterative Michael 
additions was reported (Scheme 39).89 Again, the iminium-
enamine activation is at hand. The advantage of this cascade is 
the creation and control of three contiguous stereogenic centers; 
in related Michael–aldol reactions, a single stereogenic center is 
created, due to the subsequent dehydratation step (see scheme 
37). This new methodology is based on highly chemoselective 
Michael additions and allows easy access to highly 
functionalized chiral cyclopentanes 103 from α,β-unsaturated 
aldehydes and fonctionalized malonates 102. 
 
 
 
Scheme 39. Enantioselective domino Michael–Michael. 
 
The enantioselective synthesis of epoxycyclohexanones 107 
bearing three stereogenic centers has been accomplished by a 
Michael–Darzens organocatalytic cascade between enal and β-
ketoesters 104 the latter being successively nucleophilic and 
electrophilic reagent (Scheme 40).90 The enantioselective 
Michael addition is catalyzed by the prolinol derivative and is 
followed by a Darzens reaction due to the presence in the 
reaction of a base (sodium acetate) to perform the aldol reaction. 
In a consecutive step the addition of a stronger base (K2CO3) 
deprotonates the alcohol 105 and enables the intramolecular SN2 
reaction to lead to the formation of the epoxide 106. The center 
alpha to the ketone is partially epimerized which can explain the 
low diastereoselectivity observed for products 106. However, the 
saponification of the ester function of 106 followed by 
decarboxylation gives the diastereomeric pure compounds 107. 
The good stereoselectivity observed for the other centers was 
explained by the fact that the aldol reaction is reversible and the 
irreversible epoxide cyclization is thermodynamically favourable 
for only one diastereomer of 105 (where both the chlorine and 
hydroxy groups are in axial position). 
 
Scheme 40. Organocatalytic enantioselective Michael–Darzens cascade. 
 
Recently, an organocatalytic cascade involving an 
enantioselective Michael addition, followed by a Knoevenagel 
condensation between an α,β-unsaturated aldehyde and 
dimethyl-3-oxopentadioate (108) was successfully developed 
(Scheme 41).91 This formal [3+3]–carbocycloaddition allows the 
enantioselective access to cyclohexenone 109. These are not 
isolated but treated with excess sodium borohydride to give the 
corresponding saturated cyclohexanol 110 with good yields in 
two consecutive steps. The authors have shown that the molar 
ratio of reagents is very important to induce the formation of the 
product of this cascade. Several substitutions of aromatic or 
heteroaromatic are possible for the starting aldehyde affording 
the desired products with excellent enantioselectivities (ee = 94-
99%). The use of an additive (benzoic acid) can significantly 
increase the reaction yield. This work is related to a sequence 
developed earlier for the enantioselective synthesis of chiral 
cyclohexenones from tert-butyl 3-oxobutyrate and α,β-
unsaturated aldehydes catalyzed by a diphenylprolinol silyl ether 
derivative.92 
 
 
Scheme 41. Organocatalytic enantioselective Michael–Knoevenagel cascade. 
 
Three different groups have developed independently a sequence 
involving a Michael addition followed by intramolecular 
alkylation for the synthesis of densely functionalized chiral 
cyclopropanes 112 (Scheme 42).93,94,95 This reaction is rather 
difficult to realize since the catalyst (a secondary amine) can be 
easily be poisoned by alkylation of its nitrogen atom by the 
substrate, hence stopping the reaction. These domino reactions 
generally use an α-halogenated malonate 111 and an α,β-
unsaturated aldehyde to give the corresponding cyclopropanes 
112 in very good yields and excellent enantioselectivities. It has 
been shown that the diastereoselectivity is better when the 
aldehydes are substituted by an aryl group in the 3 position (dr > 
25:1). In this sequence, it is interesting to note the ambivalent 
character of the malonic carbon atom which successively plays 
the role of nucleophile and electrophile. 
 
Scheme 42. Organocatalytic enantioselective synthesis of cyclopropanes by a 
domino Michael–Alkylation reaction. 
 
A similar strategy has been developed for highly 
enantioselective synthesis of cyclopentanones 114 (Scheme 43).96 
Nevertheless both the yields and diastereoselectivites are 
moderate. As before, the 1,3-dicarbonyl derivative 113 is 
successively nucleophile and electrophile but the reacting centers 
are different (α and γ). 
 
Scheme 43. Access of chiral cyclopentanones using a Michael–alkylation 
sequence. 
 
The next cascade consists in a Michael addition followed by a 
Morita–Baylis–Hillman (MBH) reaction. This domino sequence 
has been serendipitously discovered in an attempt to synthesize 
the cyclohexanones 116 from an unsaturated aldehyde and the 
Nazarov reagent 115 by a Michael–Michael cascade reaction 
(Scheme 44).97 Instead of the expected ketone 116, the formation 
of ketone 117 was observed resulting from a domino reaction 
involving a Michael addition followed by an intramolecular 
MBH reaction.  
 
 
 
Scheme 44. Organocatalytic enantioselective Michael–MBH cascade. 
 
After optimization of the reaction conditions, the catalyst 118 (10 
mol%) proved to be the best in terms of yield and selectivity 
combined with benzoic acid (20 mol%) as co-catalyst. This 
sequence is particularly interesting and extraordinary in a sense 
that the organocatalyst participates in two distinct catalytic cycles 
(Scheme 45). In the first cycle, the Michael acceptor is activated 
as an iminium 119 which reacts with the 1,3-dicarbonyl 
derivative 116. The aldehyde intermediate 120 is formed and the 
catalyst is regenerated. Then, it acts as the nucleophile to activate 
the double bond in the MBH reaction. The authors also showed 
that the stereoselectivity of the second step is  controlled by the 
center in the β position of the aldehyde generated during the 
Michael addtion. 
 
 
Scheme 45. Mechanism for the Michael–MBH domino reaction. 
 
An enantioselective Michael–acetalization cascade reaction 
has been realized recently for the synthesis of valuable, 
biologically active chromenones 124 from cyclic 1,3-diketones 
123 and α,β-unsaturated aldehydes (Scheme 46).98 It involves 
catalytic amounts of diphenylprolinol silyl ether 118 as the 
catalyst  and the desired 2-hydroxychromenones can be isolated 
in good yields and excellent enantioselectivities. 
 
Scheme 46. Enantioselective access to chromenones by a domino Michael–
acetalization. 
The next cascade reaction is particularly attractive since it 
allows the fast construction of the quinolizidine skeleton 127 and 
involves the formation of three new stereocenters with high 
enantioselectivity and moderate diastereoselectivity (Scheme 
47).99 The sequence includes an enantioselective Michael 
addition of the amide 125 on an α,β-unsaturated aldehyde and an 
acid catalyzed cyclization of the intermediate acyliminium ion 
126. 
 
 
Scheme 47. Enantioselective synthesis of quinalozidines. 
 
An enantioselective synthesis of α,α-disubstituted cyclopentenes 
was described featuring an N-Heterocyclic Carbene-catalyzed 
desymmetrization of 1,3-diketones (Scheme 48).100 The domino 
sequence is initiated by the formation of a conjugated Breslow-
type intermediate I which undergoes β-protonation to give enol 
intermediate II which in turn undergoes an enantioselective 
aldolization, and the resulting b-lactone undergoes loss of CO2 to 
afford the chiral cyclopentene 129. 
 
 
Scheme 48. Enantioselective synthesis of α,α-disubstituted cyclopentenes. 
  
In the above examples, the mode of activation of the catalyst 
involved the reversible formation of a covalent bond between the 
catalyst and at least one of the substrates. An alternative 
activation mode, which has its roots back to the eighties,101 
involves a network of hydrogen bonding interactions. There has 
been a tremendous number of publication relating the use of this 
kind of organocatalysts that allow efficient asymmetric 
transformations.102 
Inspired by the work of Deslongchamps (see scheme 9), a 
recent domino reaction involving a double Michael reaction 
between nitrostyrenes and γ,δ-unsaturated β-ketoesters 130 was 
reported (Scheme 49).103 The thiourea organocatalyst was 
employed to initiate the first Michael addition. Then, the addition 
of a stronger base (KOH or tetramethylguanidine) is required to 
achieve cyclization affording the cyclohexanones 131 with the 
creation and stereocontrol of three contiguous asymmetric carbon 
atoms. The high stereoselectivity of the second Michael addition 
can be explained invoking the transition state A energetically 
more favorable than the transition state B. This sequence was 
next employed as a key step in the total synthesis of (–)-
epibatidine. 
 
 
 
Scheme 49. Enantioselective synthesis of polysubstituted cyclohexanones. 
 
A similar cascade was developed in 2008 for the asymmetric 
synthesis of polysubstituted cyclopentanes 133 (Scheme 50).104 
Here also, two Michael acceptors are used in the sequence, the 
nitroalkene being slightly more reactive than the α,β-unsaturated 
ester 132). Thus, the reaction is initiated by the addition of the 
1,3-dicarbonyl derivative to the nitroalkene. The nitronate 
generated in situ then cyclizes following an intramolecular 
Michael addition to the α,β-unsaturated ester. The alkaloids 
derived from cinchona, otherwise used extensively as 
bifunctional organocatalyst,105 activate both the Michael acceptor 
and donor by hydrogen bonding interactions, which could 
account for the very good stereoselectivity of this domino 
reaction. 
 
 
Scheme 50. Enantioselective Michael–Michael domino reaction. 
 
In parallel to the previous cascade reaction, a Michael–Henry 
sequence was proposed allowing the access to chiral 
enantioenriched cyclopentanes from achiral and easily accessible 
starting materials.106 This enantioselective version of an already 
known transformation,107 is very similar to the Michael–Michael 
sequence described in scheme 50, the only difference being the 
replacement of the α,β-unsaturated ester by a ketone moiety. 
A Michael addition–intramolecular alkylation sequence was 
also used for the enantioselective synthesis of nitrocyclopropanes 
136 from methyl 2-bromomalonate (134) and nitroolefins 
(Scheme 51).108 This cascade is related to the one described 
previously (see scheme 42) but the activation mode is different 
since in the present case, the organocatalyst 135 activates the 
substrates through hydrogen bonding interactions. 
 
 
Scheme 51. Highly enantioselective synthesis of nitrocyclopropanes. 
 
Recently, an enantioselective Robinson-type annulation 
catalyzed by two structurally different chiral phosphoric acids 
has been described (Scheme 52).109 The first acid 139 catalyzed 
the enantioselective Michael addition of β-ketoesters 137 to 
methylvinyl ketone (138) and the second one 140 catalyzed a 
kinetic resolution in the intramolecular aldol reaction, thereby 
allowing to reach high enantioselectivities. 
 
 
Scheme 52. Enantioselective Robinson annulation reaction catalyzed by 
chiral phosphoric acids. 
 
4.2. Enantioselective Multicomponent Reactions 
In this section we will turn our attention to multicomponent 
enantioselective reactions using 1,3-dicarbonyl derivatives. 
These are also domino or cascade processes, but they involve at 
least three substrates with the advantage of having a wider range 
of variation in the structure of the final product.110 
The first organocatalytic enantioselective domino 
multicomponent reaction has been developed in 2001. The 
Michael acceptor (the arylidene malonate 141) was formed in 
situ by a Knoevenagel reaction catalyzed by proline between 
benzaldehyde and diethylmalonate(Scheme 53).111 Proline then 
catalyzed the enantioselective Michael addition of acetone to the 
akylidene malonate 141. At the time of the development of this 
reaction, organocatalysis was in its infancy which justify the 
moderate yield and selectivity observed. 
 
Scheme 53. Enantioselective Knoevenagel–Michael reaction. 
 
An efficient three-component synthesis of functionalized spiro 
compounds from an enone, an aldehyde and Meldrum’s acid 
involving a Knoevenagel–Diels–Alder domino sequence has 
been described(Scheme 54).112 In this reaction, the proline-
analogue catalyst plays a dual role: it allows the in situ formation 
of the alkylidene derivative 142 and activates the enone by 
formation of the enamine 143. Thus, the [4+2]-cycloaddition 
reaction takes place in a highly diastereo- and enantioselective 
manner. 
 
 
Scheme 54. The Knovenagel–Diels–Alder cascade reaction. 
 
This concept has been extended to a four-component reaction 
involving a Wittig reaction, a Knoevenagel condensation and a 
Diels-Alder reaction (Scheme 55).113 The difference with the 
preceding sequence is that the enone is generated in situ by a 
Wittig reaction between a second equivalent of aldehyde and a 
phosphorane. 
 
 
Scheme 55. The four-component Wittig–Knoevenagel–Diels–Alder cascade 
reaction. 
 
Another very interesting enantioselective multicomponent 
reaction is the asymmetric [3+2] cycloaddition of aldehydes, 
diethyl α-aminomalonate and nitroalkenes for the synthesis of 
highly substituted pyrrolidines 145 (Scheme 56).114 The reaction 
involves the in situ formation of azomethine ylides 146, between 
the aminomalonate 144 and the aldehyde, that reacts with the 
nitroalkene in a 1,3-dipolar cycloaddition with complete endo 
selectivity (>99:1). One limitation is the use of aliphatic 
aldehydes which do not participate in this reaction.  
 
 
Scheme 56. Enantioselective three-component synthesis of polysubstituted 
pyrrolidines. 
 
Preliminary results in the catalytic enantioselective Biginelli 
reaction were reported in 2003, on the use of catalytic amounts of 
CeCl3 in combination with an amide ligand derived from (R)-α-
methylbenzylamine.115 Thus, condensation of benzaldehyde with 
urea and methylacetoacetate in the presence of this catalytic 
system resulted in the formation of the desired DHPM with 24% 
ee. More significantly, in 2005, was reported the first highly 
enantioselective multicomponent Biginelli reaction using a 
recyclable ytterbium triflate coordinated with a novel chiral 
hexadentate ligand 147 bearing tertiary amine, phenol, and 
pyridine functional groups (Scheme 57).116 The desired 
heterocycles 148 were obtained in high yields with enantiomeric 
excesses up to 99%. 
 
 
Scheme 57. Ytterbium-catalyzed enantioselective Biginelli reaction. 
 
But the crucial advance was the discovery of the 
organocatalyzed enantioselective version of the Biginelli reaction 
in 2006.117,118 An enantiomerically pure chiral phosphoric acid 
149 was used as a catalyst  which allowed access to the 3,4-
dihydropyrimidin-2-(1H)-ones (DHPM) 150 with very good 
enantioselectivities (up to 97% ee, Scheme 58). More recently, 
the same group has shown that the size of the 3,3’-substituents of 
the phosphoric acid catalyst has a considerable impact on the 
control of the stereochemistry, and a fine tuning of these 
substitutents allowed the synthesis of both enantiomers of the 
same DHPM.119  
 
 
Scheme 58. Organocatalytic enantioselective Biginelli reaction. 
 
This same chiral phosphoric acid organocatalyst 149 was 
recently employed in the Biginelli reaction as a key step for the 
enantioselective synthesis of SNAP-7941, a potent melanin 
concentrating hormone receptor antagonist (Scheme 59).120 
 
 
Scheme 59. Enantioselective Biginelli reaction for the synthesis of SNAP-
7941. 
 
Organocatalytic enantioselective Biginelli reactions have also 
been studied using a proline-type organocatalyst in combination 
with an achiral Brønsted acid co-catalyst.121  
Alternatively a carbohydrate-based bifunctional primary 
amine-thiourea catalyst 151 was developed for the 
enantioselective Biginelli reaction (Scheme 60).122 In this case, 
both the hydrogen-bonding interactions and the enamine 
activation of the β-ketoester are invoked to explain the high 
stereochemical control in the dihydropyrimidine products 152. 
The use of both a Brønsted acid such as trichlorobenzoic acid 
(TCBA) and a primary amine salt co-catalysts is required in order 
to reach high enantioselectivities. 
 
Scheme 60. Enantioselective Biginelli reaction with thiourea-based 
organocatalyst. 
 
This next example of organocatalyzed multicomponent 
reaction is an enantioselective version of the modified Hantzsch 
reaction that we have exposed previously (see section 3.1). Here, 
the three components, a primary amine, an α,β-unsaturated 
aldehyde and an α,β-ketoester are mixed simultaneously in the 
presence of an organocatalyst (phosphoric acid 149) for the 
synthesis of enantiomerically enriched dihydropyridines 153 (ee 
up to 98%, Scheme 61).123 The mechanism involves the 
formation of an α,β-unsaturated imine 154 resulting from the 
condensation between the amine and aldehyde. It is activated 
through hydrogen bonding interactions with the hydroxyl group 
of the organocatalyst and undergoes nucleophilic addition of β-
ketoester. Cyclization followed by dehydration allows the 
formation of the desired DHP 153. 
 
 
Scheme 61. Enantioselective Hantzsch type reaction. 
 
A similar sequence was developed contemporaneously also 
for the synthesis of enantioenriched dihydropyridines.124 
However, this reaction is not considered as a multicomponent 
reaction since the addition of the third reagent (primary amine) is 
not simultaneous but takes place after the formation of the 
Michael adduct (between a β-ketoester or a β-diketone and an 
α,β-unsaturated aldehyde). Thus, in this specific case, the term of  
consecutive reaction is more appropriate. 
Very recently, an enantioselective four-component reaction 
has been developed to prepare bicyclic DHPs 156 (Scheme 
62).125 As before, the use of a chiral phosphoric acid 155 allowed 
to reach high enantioselectivities. 
 
 
Scheme 62. Access to enantioenriched bicyclic DHPs. 
 
Finally, a promising Michael–Michael–aldol sequence was 
developed very recently involving two different organocatalysts 
98 and 157 with orthogonal activation modes (Scheme 63).126 A 
first bifunctional base/Brønsted acid catalysis allowed the 
enantioselective formation of the Michael adduct 159 and a 
subsequent iminium catalysis allowed the second Michael 
addition between iminium 160 and previously formed adduct 
159. This organocatalytic enantioselective three-component 
cascade allowed the synthesis of highly functionalized 
cyclohexanols 158 in good yields, moderate diastereoselectivities 
and excellent enantioselectivities.        
 
Scheme 63. Dual activation organocatalysis for the enantioselective synthesis 
of cyclohexanols. 
 
5. Conclusion 
This compilation of selected examples clearly shows that 1,3-
dicarbonyl compounds are extremely valuable substrates in 
domino and/or multicomponent reactions generally involving 
iterations of simple elemental chemical steps. However, only a 
perfect mastering of kinetic and thermodynamic parameters can 
ensure a high control of selectivities. 
Of course the use of chiral substrates/auxilaries allows the 
control of chirality in these reactions, but the most significant 
contributions are found in enantioselective organocatalysis. 
These domino and/or multicomponent sequences possess 
considerable assets related to sustainable chemistry. On a 
practical point of view, the beauty and effectiveness of these 
cascade reactions are reinforced by the simplicity of the protocols 
involved in regards of the rapid increase of molecular complexity 
and functional diversity in the products. 
These reactions have already found many applications in the 
field of combinatorial and medicinal chemistry. The main 
challenge is now to develop new domino and/or multicomponent 
reactions allowing straighforward applications in total synthesis. 
The use of several distinct activation modes in the same sequence 
is expected to further increase the scope and the eco-compatible 
character of these new methodologies in organic synthesis. 
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